About Matthew M. Holub
Matt focuses his practice on resolving intellectual property disputes in the pharmaceutical industry. He primarily focuses on complex patent litigation involving the Hatch-Waxman Act and abbreviated new drug applications. He also uses his litigation experience to advise clients in complex commercial disputes involving antitrust, contract and tort claims, both within and beyond the pharmaceutical industry.
Working relentlessly to protect your investment
Before becoming an attorney, Matt worked for several years in the pharmaceutical industry, where he concentrated on brand identity and regulatory compliance of promotional activity. Now he leverages that experience to help his clients achieve their business goals through directed and focused counseling.
Practice Focus
- Intellectual property
- Patents
- Patent litigation
- Pharmaceutical and life sciences litigation
- Commercial litigation
News
-
January 24, 2023
-
August 18, 2022
-
January 28, 2022
-
August 19, 2021
-
January 29, 2021
-
August 20, 2020
-
July 20, 2020
-
January 29, 2020
-
January 25, 2018
- View All News
Publications
-
June 15, 2016
-
November 19, 2014
-
June 19, 2014